Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Persistent Postoperative Pain × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11370 Neoplasms 9098 Carcinoma, Non-Small-Cell Lung 5903 Prostatic Neoplasms 5466 Colorectal Neoplasms 5113 Lung Neoplasms 4368 Multiple Myeloma 3090 Pancreatic Neoplasms 3083 Neoplasm Metastasis 3048 Leukemia, Myeloid, Acute 3024 Carcinoma, Hepatocellular 2821 Ovarian Neoplasms 2752 Melanoma 2718 Stomach Neoplasms 2644 Lymphoma 2586 Head and Neck Neoplasms 2242 Recurrence 2194 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2146 Leukemia 2068 Brain Neoplasms 2038 Colonic Neoplasms 2000 Lymphoma, Non-Hodgkin 1956 Rectal Neoplasms 1905 Uterine Cervical Neoplasms 1867 Glioblastoma 1761 Leukemia, Lymphocytic, Chronic, B-Cell 1721 Carcinoma, Renal Cell 1661 Squamous Cell Carcinoma of Head and Neck 1608 Lymphoma, Follicular 1571 Esophageal Neoplasms 1563

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03216187 2025-10-07

PREVENT

University Hospital, Geneva

Phase 3 Terminated

Persistent Postoperative Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡